CRWV Form 144 Discloses $33.4M Founder Share Sale on 09/17/2025

Rhea-AI Filing Summary

CoreWeave, Inc. (CRWV) Form 144 notice reports a proposed sale of 281,250 common shares, with an aggregate market value of $33,398,437.50, to be sold on 09/17/2025 through Morgan Stanley Smith Barney LLC on NASDAQ. The securities were acquired as Founders Shares on 12/27/2023. The filing also lists multiple recent 10b5-1 programmed sales by related accounts between 08/20/2025 and 09/03/2025, including two prior 281,250-share sales and several smaller trust sales. The filer represents no undisclosed material adverse information and notes use of trading plans where applicable.

Positive

• Use of 10b5-1 plans is disclosed for multiple sales, indicating pre-arranged trading rather than insider-timed trades
• Form 144 compliance is observed with broker, class, quantity, and acquisition details provided

Negative

• Large proposed sale of 281,250 shares with an aggregate market value of $33,398,437.50 could increase secondary supply
• Multiple recent 10b5-1 sales by related accounts between 08/20/2025 and 09/03/2025 show significant executed dispositions

Insights

Securities Analyst

TL;DR A large founder-originated block of 281,250 CRWV shares is scheduled for sale, with multiple recent 10b5-1 transactions by related accounts.

The filing documents a planned disposition of 281,250 common shares valued at $33.4 million via Morgan Stanley on NASDAQ on 09/17/2025. The shares were acquired as founders' shares on 12/27/2023. The notice also discloses executed 10b5-1 sales from affiliated entities and trusts during August and September 2025, indicating pre-arranged programmed selling activity rather than ad-hoc market exits. For investors, the immediate implication is additional secondary supply entering the market on the stated date; the filing does not include company operational or financial results.

Corporate Governance Expert

TL;DR This disclosure shows compliance with Rule 144 and use of Rule 10b5-1 plans, with significant insider-related transactions recently executed.

The document shows proper Rule 144 notice procedures: identification of securities, acquisition as founders' shares, broker details, and representation about material nonpublic information. Multiple 10b5-1 sales by similarly named accounts are disclosed with gross proceeds listed, demonstrating reliance on pre-established plans to execute sales. From a governance perspective, the filing provides transparent transaction details but does not explain the rationale for the sales, which is outside the scope of Form 144.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	281250	33398437.50	370470348	09/17/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/27/2023	Founders Shares	Issuer			281250	12/27/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for WEST CLAY CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/03/2025	281250	25487803.13
10b5-1 Sales for YOLO APV TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/02/2025	19410	1808187.08
10b5-1 Sales for YOLO ECV TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/02/2025	19410	1808187.08
10b5-1 Sales for WEST CLAY CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/20/2025	281250	24777421.88
10b5-1 Sales for YOLO APV TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/20/2025	21531	1896827.27
10b5-1 Sales for YOLO ECV TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/20/2025	21531	1896827.27

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares of CRWV are proposed for sale in this Form 144?

The notice proposes sale of 281,250 common shares of CRWV with an aggregate market value of $33,398,437.50.

When is the proposed sale scheduled to occur?

The Form 144 lists an approximate sale date of 09/17/2025 for the 281,250 shares.

How were the securities being sold originally acquired?

The securities were acquired as Founders Shares on 12/27/2023.

Which broker is handling the proposed sale?

The broker named is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY.

Have related 10b5-1 sales occurred recently?

Yes. The filing discloses several 10b5-1 sales by related accounts between 08/20/2025 and 09/03/2025, including prior 281,250-share transactions.